Pfizer has spent years on the receiving end of the FDA's wrath for continued manufacturing issues surrounding the drugmaker's 2015 buyout of Hospira. Now, after a year of trying to right the ship with ...
Hikma is set to introduce four new sterile injectable medications in Canada. All of the medications, which will launch soon, represent the first or second generic versions on the Canadian market and ...
The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...
Over the past few years, drug shortages have become an ever-present challenge for hospital pharmacies, with shortages at their highest in over a decade1 and the majority of those, 53 percent, were for ...
What Endo thought was a real deal has turned into a kill deal. The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables ...
GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...
Ottawa, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The CDMO aseptic filling solutions market is experiencing robust growth and is expected to continue booming throughout the prospective period, propelled by ...
Pune, Maharashtra, India, January 18 2021 (Wiredrelease) MarketResearch.Biz –:An extensive and elaborate primary research on Global Sterile Injectable Market report sheds light on numerous facets such ...
Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...
PAI Pharma has acquired Nivagen Pharmaceuticals in a move it said was aimed at expanding the domestic supply of sterile injectable drugs. Nivagen operates a recently built aseptic manufacturing ...
WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...
The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results